• Tidak ada hasil yang ditemukan

TMEPAI genome editing in triple negative breast cancer cells

N/A
N/A
Protected

Academic year: 2017

Membagikan "TMEPAI genome editing in triple negative breast cancer cells"

Copied!
5
0
0

Teks penuh

Loading

Gambar

Figure 1.  CRISPR-Cas9 system to knock-out TMEPAI. (A) CRISPR-Cas9 systems in Hs578T, the triple negative breast cancer cell
Figure 2. Establish knock-out TMEPAI in triple negative breast cancer cell line. The expression of TMEPAI protein in WT and KO Hs578T cells was measured by western blot analysis after TGF-β treatment

Referensi

Dokumen terkait

Penelitian ini merupakan penelitian deskriptif dengan data sekunder berupa data pasien rawat inap triple negative breast cancer di Bagian Bedah Onkologi Rumah Sakit Umum

Triple Negative Breast Cancer merupakan ranah penelitian yang penting karena karsinoma tipe ini memiliki prognosis yang buruk untuk disease freesurvival dan

Mengetahui hubungan antara Tumor-Infiltrating Lymphocytes (TILs) dengan grading histopatologi pada pasien Triple Negative Breast Cancer (TNBC) di RSUP Haji Adam Malik

Penelitian ini merupakan penelitian deskriptif dengan data sekunder berupa data pasien rawat inap triple negative breast cancer di Bagian Bedah Onkologi Rumah Sakit Umum

RESULTS: By using immunohistochemistry staining panel of CD44, CD24, Twist, Claudin 7, CK5, CK8/18, EMA, E-Cadherin, Ki-67, a total 67 breast tumour samples with TNBC were classified

https://doi.org/10.3889/oamjms.2022.6882 eISSN: 1857-9655 Category: B - Clinical Sciences Section: Oncology Chemotherapy Effect on Estradiol Levels in Patients with Triple-negative

In breast cancer, higher TIL level is associated with higher pathologic complete re- sponse pCR after neoadjuvant chemotherapy NAC as well as better prognosis in patients with

Several reports have described using the CRISPR/Cas9 system in cucurbit species, and although its application has many bottlenecks, the targeted knock-out of the CENH3 gene will allow